Migenix, Cadence start CPI-226 Phase III

Migenix (TSE:MGI; MGIFF) said partner Cadence (San Diego, Calif.) started a Phase III trial of CPI-226 omiganan 1% gel to prevent catheter-related infections. The company has an SPA for the evaluation...